| 1 |
Baran E, D’ascenzo M, Bosia J, Montaña P. Abdominal ultrasound findings in adult patients with cystic fibrosis. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.07.002] [Reference Citation Analysis]
|
| 2 |
Anstee QM, Castera L, Loomba R. Impact of non-invasive biomarkers on hepatology practice: Past, present and future. J Hepatol 2022;76:1362-78. [PMID: 35589256 DOI: 10.1016/j.jhep.2022.03.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 3 |
Baran E, D’ascenzo M, Bosia J, Montaña P. Hallazgos de la ecografía abdominal en pacientes adultos con fibrosis quística. Revista de Gastroenterología de México 2022. [DOI: 10.1016/j.rgmx.2022.05.003] [Reference Citation Analysis]
|
| 4 |
Cardoso AC, Figueiredo-Mendes C, Villela-Nogueira CA, Marcellin P. Staging Fibrosis in Chronic Viral Hepatitis. Viruses 2022;14:660. [PMID: 35458391 DOI: 10.3390/v14040660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Bergasa NV. Approach to the Patient with Liver Disease. Clinical Cases in Hepatology 2022. [DOI: 10.1007/978-1-4471-4715-2_2] [Reference Citation Analysis]
|
| 6 |
Ruan D, Shi Y, Jin L, Yang Q, Yu W, Ren H, Zheng W, Chen Y, Zheng N, Zheng M. An ultrasound image-based deep multi-scale texture network for liver fibrosis grading in patients with chronic HBV infection. Liver Int 2021;41:2440-54. [PMID: 34219353 DOI: 10.1111/liv.14999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Wei MT, Le MH, Landis C, Trinh H, Wong G, Le A, Zhang J, Cheung R, Nguyen MH. Evaluation of ethnic influence in the application of a hepatocellular carcinoma predictive model for chronic hepatitis C. J Med Virol 2021. [PMID: 34219250 DOI: 10.1002/jmv.27168] [Reference Citation Analysis]
|
| 8 |
Parlati L, Hollande C, Pol S. Treatment of hepatitis C virus infection. Clin Res Hepatol Gastroenterol 2021;45:101578. [PMID: 33272891 DOI: 10.1016/j.clinre.2020.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 9 |
Sun Q, Fan W, Liu Y, Zou Y, Wiseman N, Kou Z, Han P. Characterization of brain microstructural abnormalities in cirrhotic patients without overt hepatic encephalopathy using diffusion kurtosis imaging. Brain Imaging Behav 2020;14:627-38. [PMID: 31538276 DOI: 10.1007/s11682-019-00141-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Suh HJ, Choe PG, Song KH, Park WB, Bang JH, Kim ES, Kim HB, Park SW, Oh MD, Kim NJ. Prevalence of cryptococcal antigenemia in hospitalized patients with liver cirrhosis. Med Mycol 2020;58:207-10. [PMID: 31075793 DOI: 10.1093/mmy/myz045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Zhou B, Shao J, Schaefbauer KJ, Egan AM, Carmona EM, Limper AH, Zhang X. Grading Bleomycin-Induced Pulmonary Fibrosis in ex vivo Mouse Lungs Using Ultrasound Image Analysis. J Ultrasound Med 2021;40:763-70. [PMID: 32865263 DOI: 10.1002/jum.15448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 12 |
Kim DY, Kim UJ, Yu Y, Kim SE, Kang SJ, Jun KI, Kang CK, Song KH, Choe PG, Kim ES, Kim HB, Jang HC, Jung SI, Oh MD, Park KH, Kim NJ. Microbial Etiology of Pyogenic Vertebral Osteomyelitis According to Patient Characteristics. Open Forum Infect Dis 2020;7:ofaa176. [PMID: 32523973 DOI: 10.1093/ofid/ofaa176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 13 |
Shiha G, Mousa N. Noninvasive Biomarkers for Liver Fibrosis. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_36] [Reference Citation Analysis]
|
| 14 |
Yonis AG, Abdallash ASA, Ahmed M, Mohammed Osman AM. CHARACTERIZATION OF PORTAL HYPERTENSION IN GEZIRASTATE (SUDAN) USING ULTRASOUND. Int J Res Granthaalayah 2019;7:30-38. [DOI: 10.29121/granthaalayah.v7.i7.2019.711] [Reference Citation Analysis]
|
| 15 |
Menard M, Lecoindre A, Cadoré JL, Chevallier M, Pagnon A, Hernandez J, Leal RO, Hugonnard M, Miette V, Destro M, Rannou B, Benchekroun G, Lecoindre P. Use of serum biomarkers in staging of canine hepatic fibrosis. J Vet Diagn Invest 2019;31:665-73. [PMID: 31347473 DOI: 10.1177/1040638719866881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 16 |
Pol S, Lagaye S. The remarkable history of the hepatitis C virus. Microbes Infect 2019;21:263-70. [PMID: 31295571 DOI: 10.1016/j.micinf.2019.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 17 |
Chen Y, Wang Y, Chen Y, Yu Z, Chi X, Hu KQ, Li Q, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chi W, Dong Z, Wang X, Li Z, Xiao H, Chen D, Bai W, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Sun H, Deng M, Qi X, Zhang Z, Qi X, Yang Y. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B. Clin Transl Gastroenterol 2019;10:1-12. [PMID: 31033506 DOI: 10.14309/ctg.0000000000000033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 18 |
Pol S, Lagaye S. The remarkable history of the hepatitis C virus. Genes Immun. 2019;20:436-446. [PMID: 31019253 DOI: 10.1038/s41435-019-0066-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 19 |
Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki JP, Zoulim F, Asselah T, Marcellin P, Thabut D, Leroy V, Tran A, Habersetzer F, Samuel D, Guyader D, Chazouilleres O, Mathurin P, Metivier S, Alric L, Riachi G, Gournay J, Abergel A, Cales P, Ganne N, Loustaud-Ratti V, D'Alteroche L, Causse X, Geist C, Minello A, Rosa I, Gelu-Simeon M, Portal I, Raffi F, Bourliere M, Pol S; French ANRS CO22 Hepather cohort. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 2019;393:1453-64. [PMID: 30765123 DOI: 10.1016/S0140-6736(18)32111-1] [Cited by in Crossref: 357] [Cited by in F6Publishing: 334] [Article Influence: 89.3] [Reference Citation Analysis]
|
| 20 |
Fuhrmann I, Brünn K, Probst U, Verloh N, Stroszczynski C, Jung EM, Wiggermann P, Haimerl M. Proof of principle: Estimation of liver function using color coded Doppler sonography of the portal vein. CH 2019;70:585-594. [DOI: 10.3233/ch-189323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 21 |
Maruyama H, Kato N. Advances in ultrasound diagnosis in chronic liver diseases. Clin Mol Hepatol 2019;25:160-7. [PMID: 30773001 DOI: 10.3350/cmh.2018.1013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 22 |
Nielsen M, Villesen I, Sinkeviciute D, Bay-jensen A, Karsdal M. Type III collagen. Biochemistry of Collagens, Laminins and Elastin 2019. [DOI: 10.1016/b978-0-12-817068-7.00003-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 23 |
Nielsen MJ, Karsdal MA, Krag A, Leeming DJ. Extracellular Matrix Remodeling with Focus on Biochemical Markers in Liver Fibrosis: Limitations and Possibilities. The Human Gut-Liver-Axis in Health and Disease 2019. [DOI: 10.1007/978-3-319-98890-0_15] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 24 |
Kondo R, Kage M, Iijima H, Fujimoto J, Nishimura T, Aizawa N, Akiba J, Naito Y, Kusano H, Nakayama M, Mihara Y, Tanigawa M, Yano H. Pathological findings that contribute to tissue stiffness in the spleen of liver cirrhosis patients. Hepatol Res 2018;48:1000-7. [PMID: 29766631 DOI: 10.1111/hepr.13195] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 25 |
Ceplecha V, Řeháková K, Lendon C, Proks P, Škorič M, Grinwis GC, Hřibová B, Vávra M, Lorenzová J, Crha M. Hyaluronic acid and TGF-β1 in dogs with hepatobiliary diseases. Acta Vet Brno 2018;87:231-40. [DOI: 10.2754/avb201887030231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 26 |
Iijima H, Nishimura T. Ultrasound diagnosis of hepaticfibrosis and steatosis. Acta hepatologica Japonica 2018;59:384-392. [DOI: 10.2957/kanzo.59.384] [Reference Citation Analysis]
|
| 27 |
Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Primers 2018;4:16. [PMID: 30115921 DOI: 10.1038/s41572-018-0014-7] [Cited by in Crossref: 421] [Cited by in F6Publishing: 434] [Article Influence: 84.2] [Reference Citation Analysis]
|
| 28 |
Kotani K, Kawabe J, Higashiyama S, Yoshida A, Kawamura E, Tamori A, Shiomi S, Kawada N. Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis: A retrospective observational study. Medicine (Baltimore) 2018;97:e11765. [PMID: 30075603 DOI: 10.1097/MD.0000000000011765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Kobayashi K, Maruyama H, Kiyono S, Ogasawara S, Suzuki E, Ooka Y, Chiba T, Kato N, Yamaguchi T. Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis. J Gastroenterol 2018;53:652-9. [PMID: 28821966 DOI: 10.1007/s00535-017-1378-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 30 |
Maruyama H, Yokosuka O. Ultrasonography for Noninvasive Assessment of Portal Hypertension. Gut Liver. 2017;11:464-473. [PMID: 28267700 DOI: 10.5009/gnl16078] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 31 |
Calès P, Boursier J, Oberti F, Moal V, Fouchard Hubert I, Bertrais S, Hunault G, Rousselet MC; multicentric groups (SNIFF, ANRS HC 23). A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis. Hepatol Commun 2018;2:455-66. [PMID: 29619423 DOI: 10.1002/hep4.1161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 32 |
Pandey P, Pandey A, Dillhoff M, Schmidt C, Kamel IR, Pawlik TM. Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy. J Gastrointest Surg 2018;22:344-60. [PMID: 28924922 DOI: 10.1007/s11605-017-3562-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 33 |
Wang D, Zhang S, Chen Y, Hu B, Lu C. Low expression of NKD2 is associated with enhanced cell proliferation and poor prognosis in human hepatocellular carcinoma. Human Pathology 2018;72:80-90. [DOI: 10.1016/j.humpath.2017.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 34 |
Pateu E, Oberti F, Calès P. The noninvasive diagnosis of esophageal varices and its application in clinical practice. Clin Res Hepatol Gastroenterol 2018;42:6-16. [PMID: 28870440 DOI: 10.1016/j.clinre.2017.07.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 35 |
Haimerl M, Brünn K, Poelsterl S, Beyer L, Wiesinger I, Stroszczynski C, Jung E, Wiggermann P, Jünger M, Krüger-genge A, Jung F. Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion. CH 2017;67:373-82. [DOI: 10.3233/ch-179217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 36 |
Ito K, Murotani K, Nakade Y, Inoue T, Nakao H, Sumida Y, Kamada Y, Yoneda M. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: A meta-analysis. J Gastroenterol Hepatol 2017;32:1922-30. [PMID: 28406534 DOI: 10.1111/jgh.13802] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 37 |
Kang J, Lee M. Noninvasive Diagnostic and Prognostic Assessment Tools for Liver Fibrosis and Cirrhosis in Patients with Chronic Liver Disease. Liver Cirrhosis - Update and Current Challenges 2017. [DOI: 10.5772/intechopen.68317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 38 |
Li L, Duan M, Chen W, Jiang A, Li X, Yang J, Li Z. The spleen in liver cirrhosis: revisiting an old enemy with novel targets. J Transl Med 2017;15:111. [PMID: 28535799 DOI: 10.1186/s12967-017-1214-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 39 |
Haimerl M, Poelsterl S, Beyer L, Wiesinger I, Nießen C, Stroszczynski C, Wiggermann P, Jung E, Jung F, Gori T. Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion. CH 2017;64:435-46. [DOI: 10.3233/ch-168112] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 40 |
Nielsen MJ, Leeming DJ, Karsdal MA, Krag A. Biomarkers of Extracellular Matrix Remodeling in Liver Diseases. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_14] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 41 |
Kobayashi K, Maruyama H, Kiyono S, Sekimoto T, Kondo T, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Portal response related to shunt occlusion by balloon-occluded retrograde transvenous obliteration may determine the prognosis of cirrhosis. Hepatol Res 2016;46:1321-9. [PMID: 26931092 DOI: 10.1111/hepr.12690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 42 |
Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis. Scand J Gastroenterol 2016;51:236-44. [PMID: 26357874 DOI: 10.3109/00365521.2015.1081275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 43 |
Abbattista T, Ridolfi F, Consalvo GT, Brunelli E. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography. J Ultrasound Med 2016;35:2121-8. [PMID: 27503751 DOI: 10.7863/ultra.15.09026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 44 |
Babaei Z, Parsian H. Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application. Hepatobiliary Pancreat Dis Int 2016;15:131-40. [PMID: 27020628 DOI: 10.1016/s1499-3872(16)60062-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 45 |
Stankovic Z. Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol 2016; 22(1): 89-102 [PMID: 26755862 DOI: 10.3748/wjg.v22.i1.89] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 46 |
Nielsen M, Karsdal M. Type III Collagen. Biochemistry of Collagens, Laminins and Elastin 2016. [DOI: 10.1016/b978-0-12-809847-9.00003-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Hanai T, Shiraki M, Ohnishi S, Miyazaki T, Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis. Hepatol Res 2015;45:1083-90. [PMID: 25565570 DOI: 10.1111/hepr.12473] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 48 |
Calès P, Boursier J, Oberti F, Bardou D, Zarski JP, de Lédinghen V; Multicentric Group. Cirrhosis Diagnosis and Liver Fibrosis Staging: Transient Elastometry Versus Cirrhosis Blood Test. J Clin Gastroenterol 2015;49:512-9. [PMID: 24828359 DOI: 10.1097/MCG.0000000000000138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 49 |
Meng N, Gao X, Yan W, Wang M, Liu P, Lu XD, Zhang SJ, Lu YQ, Tang WX. Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses. J Huazhong Univ Sci Technolog Med Sci. 2015;35:230-234. [PMID: 25877357 DOI: 10.1007/s11596-015-1416-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 50 |
Janny S, Eurin M, Dokmak S, Toussaint A, Farges O, Paugam-Burtz C. Assessment of the external validity of a predictive score for blood transfusion in liver surgery. HPB (Oxford) 2015;17:357-61. [PMID: 25516363 DOI: 10.1111/hpb.12376] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 51 |
Huang Z, Chen X, Zhao Q, Zheng Y, Peng L, Gao Z, Zhao Z. An albumin, collagen IV, and longitudinal diameter of spleen scoring system superior to APRI for assessing liver fibrosis in chronic hepatitis B patients. International Journal of Infectious Diseases 2015;31:18-22. [DOI: 10.1016/j.ijid.2014.10.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 52 |
Baik SK, Kim MY, Jeong WK. Diagnostic imaging modalities. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch03] [Reference Citation Analysis]
|
| 53 |
Nielsen MJ, Leeming DJ, Karsdal MA, Krag A. Biomarkers of Extracellular Matrix Remodeling in Liver Diseases. Biomarkers in Disease: Methods, Discoveries and Applications 2015. [DOI: 10.1007/978-94-007-7742-2_14-1] [Reference Citation Analysis]
|
| 54 |
Mueller S, Seitz HK, Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol 2014; 20(40): 14626-14641 [PMID: 25356026 DOI: 10.3748/wjg.v20.i40.14626] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 83] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 55 |
Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 147] [Cited by in F6Publishing: 152] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 56 |
Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014; 20(15): 4300-4315 [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 73] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 57 |
Barr DC, Hussain HK. Magnetic Resonance Imaging in Cirrhosis: What’s New? Topics in Magnetic Resonance Imaging 2014;23:129-49. [DOI: 10.1097/rmr.0000000000000017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 58 |
Ozkurt H, Keskiner F, Karatag O, Alkim C, Erturk SM, Basak M. Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol 2014;11:e3555. [PMID: 24693297 DOI: 10.5812/iranjradiol.3555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 59 |
Gabr SA, Alghadir AH. Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers. Virusdisease 2014;25:91-100. [PMID: 24426315 DOI: 10.1007/s13337-013-0182-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 60 |
Tao R, Zhang J, You Z, Wei L, Fan Y, Cui J, Wang J. The thalamus in cirrhotic patients with and without hepatic encephalopathy: a volumetric MRI study. Eur J Radiol. 2013;82:e715-e720. [PMID: 23981388 DOI: 10.1016/j.ejrad.2013.07.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 61 |
Wang Y, Wu Z, Ju Y, Cao L, Shi L, Tong F, Jiang X, Zhu C. Tissue Doppler imaging and tissue strain imaging for the evaluation of hepatic fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol 2013;39:1527-35. [PMID: 23791352 DOI: 10.1016/j.ultrasmedbio.2013.02.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 62 |
Mak TM, Huang YP, Zheng YP. Liver fibrosis assessment using transient elastography guided with real-time B-mode ultrasound imaging: a feasibility study. Ultrasound Med Biol 2013;39:956-66. [PMID: 23562022 DOI: 10.1016/j.ultrasmedbio.2013.01.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 63 |
Trabut J, Pol S. Alcool et marqueurs biologiques. Revue Francophone des Laboratoires 2013;2013:25-27. [DOI: 10.1016/s1773-035x(13)71851-3] [Reference Citation Analysis]
|
| 64 |
Armutcu F, Akyol S, Ucar F, Erdogan S, Akyol O. Markers in nonalcoholic steatohepatitis. Adv Clin Chem 2013;61:67-125. [PMID: 24015600 DOI: 10.1016/b978-0-12-407680-8.00004-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 65 |
Parkes J, Guha IN, Harris S, Rosenberg WM, Roderick PJ. Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease. Comp Hepatol. 2012;11:5. [PMID: 23273224 DOI: 10.1186/1476-5926-11-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Ridolfi F, Abbattista T, Busilacchi P, Brunelli E. Contrast-enhanced ultrasound evaluation of hepatic microvascular changes in liver diseases. World J Gastroenterol 2012; 18(37): 5225-5230 [PMID: 23066317 DOI: 10.3748/wjg.v18.i37.5225] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
|
| 67 |
Ito K, Kuno A, Ikehara Y, Sugiyama M, Saito H, Aoki Y, Matsui T, Imamura M, Korenaga M, Murata K, Masaki N, Tanaka Y, Hige S, Izumi N, Kurosaki M, Nishiguchi S, Sakamoto M, Kage M, Narimatsu H, Mizokami M. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients. Hepatology 2012;56:1448-56. [PMID: 22535703 DOI: 10.1002/hep.25815] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 68 |
Tao R, Zhang J, Dai Y, You Z, Fan Y, Cui J, Wang J. An in vitro and in vivo analysis of the correlation between susceptibility-weighted imaging phase values and R2* in cirrhotic livers. PLoS One 2012;7:e45477. [PMID: 23029037 DOI: 10.1371/journal.pone.0045477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 69 |
Kim M, Lee J. Assessment of Liver Stiffness Measurement: Novel Intraoperative Blood Loss Predictor? World J Surg 2013;37:185-91. [DOI: 10.1007/s00268-012-1774-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 70 |
Cho HJ, Kim SS, Ahn SJ, Bae CB, Kim HG, Kim YJ, Lee SK, Song GW, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW, Cheong JY. Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B. Clin Biochem 2012;45:1564-7. [PMID: 22885475 DOI: 10.1016/j.clinbiochem.2012.07.107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 71 |
Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, Ross MJ, Wyatt CM; INSIGHT SMART Study Group., ESPRIT Study Group. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One 2012;7:e40245. [PMID: 22911697 DOI: 10.1371/journal.pone.0040245] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 72 |
Domingues AL, Medeiros TB, Lopes EP. Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni. Mem Inst Oswaldo Cruz 2011;106:802-7. [PMID: 22124551 DOI: 10.1590/s0074-02762011000700004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 73 |
Sini M, Sorbello O, Civolani A, Liggi M, Demelia L. Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease. Dig Liver Dis 2012;44:487-91. [PMID: 22261353 DOI: 10.1016/j.dld.2011.12.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 74 |
D'amico G, Malizia G. Cirrhosis of the liver. Textbook of Clinical Gastroenterology and Hepatology 2012. [DOI: 10.1002/9781118321386.ch97] [Reference Citation Analysis]
|
| 75 |
Sebastiani G, Alberti A. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? J Viral Hepat 2012;19 Suppl 1:18-32. [PMID: 22233410 DOI: 10.1111/j.1365-2893.2011.01518.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 76 |
Neuman MG, Schmilovitz-Weiss H, Hilzenrat N, Bourliere M, Marcellin P, Trepo C, Mazulli T, Moussa G, Patel A, Baig AA, Cohen L. Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int J Hepatol 2012;2012:231210. [PMID: 22530132 DOI: 10.1155/2012/231210] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 77 |
Adrover R, Cocozzella D, Ridruejo E, García A, Rome J, Podestá JJ. Breath-ammonia testing of healthy subjects and patients with cirrhosis. Dig Dis Sci 2012;57:189-95. [PMID: 21842240 DOI: 10.1007/s10620-011-1858-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 78 |
Xu LH, Fang JP, Xu HG, Weng WJ. Evaluation of hepatic iron overload in Chinese children with β-thalassemia major. Pediatr Hematol Oncol 2011;28:702-7. [PMID: 21970505 DOI: 10.3109/08880018.2011.603820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 79 |
Rath T, Roderfeld M, Güler C, Wenzel C, Graf J, Beitinger F, Roeb E, Zachoval R. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis. Scand J Gastroenterol 2011;46:1369-80. [PMID: 21905976 DOI: 10.3109/00365521.2011.613949] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 80 |
Morikawa H, Kawada N. Non-invasive diagnosis of liver fibrosis. Clin J Gastroenterol 2011;4:283-91. [DOI: 10.1007/s12328-011-0248-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 81 |
Yamamoto Y, Shimada K, Sakamoto Y, Esaki M, Nara S, Kosuge T. Preoperative identification of intraoperative blood loss of more than 1,500 mL during elective hepatectomy. Journal of Hepato-Biliary-Pancreatic Sciences 2011;18:829-38. [DOI: 10.1007/s00534-011-0399-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 82 |
Omran MM, Farid K, Emran TM, Attallah AA. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J Gastroenterol. 2011;12:74-79. [PMID: 21684477 DOI: 10.1016/j.ajg.2011.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 83 |
Guilbert T, Odin C, Le Grand Y, Gailhouste L, Turlin B, Ezan F, Désille Y, Baffet G, Guyader D. A robust collagen scoring method for human liver fibrosis by second harmonic microscopy. Opt Express 2010;18:25794-807. [PMID: 21164924 DOI: 10.1364/OE.18.025794] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 84 |
Ahmad W, Ijaz B, Gull S, Asad S, Khaliq S, Jahan S, Sarwar MT, Kausar H, Sumrin A, Shahid I. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virol J. 2011;8:53. [PMID: 21299910 DOI: 10.1186/1743-422x-8-53] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 85 |
Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One. 2011;6:e16081. [PMID: 21283674 DOI: 10.1371/journal.pone.0016081;] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 86 |
Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One. 2011;6:e16081. [PMID: 21283674 DOI: 10.1371/journal.pone.0016081] [Cited by in Crossref: 215] [Cited by in F6Publishing: 234] [Article Influence: 17.9] [Reference Citation Analysis]
|
| 87 |
Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int. 2011;5:625-634. [PMID: 21484142 DOI: 10.1007/s12072-010-9240-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 88 |
Veillon P, Gallois Y, Moal V, Fouchard-Hubert I, Charles I, Larcher F, Dib N, Boursier J, Oberti F, Laafi J, Guéchot J, Balan V, Calès P, Lunel-Fabiani F. Assessment of new hyaluronic acid assays and their impact on FibroMeter scores. Clin Chim Acta 2011;412:347-52. [PMID: 21075099 DOI: 10.1016/j.cca.2010.11.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 89 |
Sebastiani G, Gkouvatsos K, Plebani M. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. Clin Chem Lab Med. 2011;49:13-32. [PMID: 20961196 DOI: 10.1515/cclm.2011.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 90 |
Lu Y, Liu J, Lin C, Wang H, Jiang Y, Wang J, Yang P, He F. Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasma. BMC Gastroenterol. 2010;10:115. [PMID: 20939925 DOI: 10.1186/1471-230x-10-115] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 91 |
Ishibashi H, Maruyama H, Takahashi M, Fujiwara K, Imazeki F, Yokosuka O. Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography. Liver Int 2010;30:1355-63. [PMID: 20704652 DOI: 10.1111/j.1478-3231.2010.02315.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 92 |
Castel H, Mathurin P. Alcoholic Liver Disease. Evidence‐Based Gastroenterology and Hepatology 2010. [DOI: 10.1002/9781444314403.ch28] [Reference Citation Analysis]
|
| 93 |
Calès P, Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Dib N, Zarski JP, Rousselet MC. Optimization and robustness of blood tests for liver fibrosis and cirrhosis. Clin Biochem. 2010;43:1315-1322. [PMID: 20713037 DOI: 10.1016/j.clinbiochem.2010.08.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 94 |
Ratziu V. Serum fibrosis markers: death by validation or a leap of faith? J Hepatol 2010;53:222-4. [PMID: 20546961 DOI: 10.1016/j.jhep.2010.04.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 95 |
Kim KS, Hur W, Park SJ, Hong SW, Choi JE, Goh EJ, Yoon SK, Hahn SK. Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots. ACS Nano 2010;4:3005-14. [PMID: 20518553 DOI: 10.1021/nn100589y] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 96 |
Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH. Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease. Korean J Hepatol. 2009;15:454-463. [PMID: 20037264 DOI: 10.3350/kjhep.2009.15.4.454] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 97 |
Nguyen-khac E, Saint-leger P, Tramier B, Coevoet H, Capron D, Dupas J. Noninvasive Diagnosis of Large Esophageal Varices by Fibroscan: Strong Influence of the Cirrhosis Etiology: FIBROSCAN FOR LARGE VARICES PREDICTION. Alcoholism: Clinical and Experimental Research 2010. [DOI: 10.1111/j.1530-0277.2010.01191.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 98 |
Seki M, Asano K, Sakai M, Kanno N, Teshima K, Edamura K, Tanaka S. Serum hyaluronic acid in dogs with congenital portosystemic shunts. Journal of Small Animal Practice 2010;51:260-3. [DOI: 10.1111/j.1748-5827.2010.00934.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 99 |
Takahashi H, Ono N, Eguchi Y, Eguchi T, Kitajima Y, Kawaguchi Y, Nakashita S, Ozaki I, Mizuta T, Toda S, Kudo S, Miyoshi A, Miyazaki K, Fujimoto K. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int 2010;30:538-45. [PMID: 19874490 DOI: 10.1111/j.1478-3231.2009.02130.x] [Cited by in Crossref: 167] [Cited by in F6Publishing: 183] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 100 |
Abdelmoneim SS, Talwalkar J, Sethi S, Kamath P, Fathalla MM, Kipp BR, Campion MB, Clayton AC, Halling KC, Shah VH. A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension. Liver Int 2010;30:191-7. [PMID: 19840257 DOI: 10.1111/j.1478-3231.2009.02132.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 101 |
Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS. Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease. J Korean Med Sci 2010;25:67-74. [PMID: 20052350 DOI: 10.3346/jkms.2010.25.1.67] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 102 |
Bureau C. Évaluer la fibrose: Pourquoi? Comment? Pour qui? Post’U FMC-HGE 2010. [DOI: 10.1007/978-2-8178-0097-4_35] [Reference Citation Analysis]
|
| 103 |
Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, Denninger MH, Vidaud D, Condat B, Hadengue A, Primignani M, Garcia-Pagan JC, Janssen HL, Valla D; European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010;51:210-8. [PMID: 19821530 DOI: 10.1002/hep.23259] [Cited by in Crossref: 359] [Cited by in F6Publishing: 375] [Article Influence: 27.6] [Reference Citation Analysis]
|
| 104 |
Qian J, Zhang JS, Wang XQ, Ji JL, Mei S. Fenretinide stimulates the apoptosis of hepatic stellate cells and ameliorates hepatic fibrosis in mice. Hepatol Res 2009;39:1229-47. [PMID: 19788699 DOI: 10.1111/j.1872-034X.2009.00562.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 105 |
Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S, Gallois Y, Le Tallec V, Oberti F, Fouchard-Hubert I, Dib N, Rousselet MC, Konaté A, Amrani N, de Ledinghen V, Calès P. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int 2009;29:1507-15. [PMID: 19725892 DOI: 10.1111/j.1478-3231.2009.02101.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 106 |
Leroy V. Other non-invasive markers of liver fibrosis. Gastroenterol Clin Biol. 2008;32:52-57. [PMID: 18973846 DOI: 10.1016/s0399-8320(08)73993-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 107 |
Calès P, Boursier J, Oberti F, Hubert I, Gallois Y, Rousselet MC, Dib N, Moal V, Macchi L, Chevailler A. FibroMeters: a family of blood tests for liver fibrosis. Gastroenterol Clin Biol. 2008;32:40-51. [PMID: 18973845 DOI: 10.1016/s0399-8320(08)73992-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 108 |
Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther 2009;30:557-76. [PMID: 19519733 DOI: 10.1111/j.1365-2036.2009.04062.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 109 |
Diarra M, Konaté A, Diarra A, Kane M, Touré M, Dembélé M, Bagayogo M, Sidibé S, Traoré H-, Maïga M-. Intérêt de l’échographie dans le diagnostic de la cirrhose en milieu tropical. J Afr Hepato Gastroenterol 2009;3:125-129. [DOI: 10.1007/s12157-009-0095-8] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 110 |
Pissaia A Jr, Borderie D, Bernard D, Scatton O, Calmus Y, Conti F. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology. Transplant Proc. 2009;41:679-681. [PMID: 19328955 DOI: 10.1016/j.transproceed.2008.12.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 111 |
Sayed DM, El-attar MM, Hussein AARM. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids. Diagn Cytopathol 2009;37:498-504. [DOI: 10.1002/dc.21047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 112 |
Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009; 15(18): 2190-2203 [PMID: 19437558 DOI: 10.3748/wjg.15.2190] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 61] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 113 |
Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009;16:300-14. [PMID: 19254351 DOI: 10.1111/j.1365-2893.2009.01087.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 114 |
Calès P, Boursier J, Hubert I, Dib N, Oberti F. Which would you prefer for a liver fibrosis test: A limited fixed menu or a gourmet buffet? Gastroentérologie Clinique et Biologique 2009;33:388-389. [DOI: 10.1016/j.gcb.2009.02.033] [Reference Citation Analysis]
|
| 115 |
Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, Goto T, Yoshida H, Kanai F, Sugioka Y, Ikeda H, Shiina S, Kawabe T, Omata M. Comparison of liver biopsy and transient elastography based on clinical relevance. Can J Gastroenterol 2008;22:753-7. [PMID: 18818788 DOI: 10.1155/2008/306726] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 116 |
Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 2009;50:17-35. [PMID: 19022517 DOI: 10.1016/j.jhep.2008.10.016] [Cited by in Crossref: 138] [Cited by in F6Publishing: 149] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 117 |
Boursier J, Bacq Y, Halfon P, Leroy V, de Ledinghen V, de Muret A, Bourlière M, Sturm N, Foucher J, Oberti F, Rousselet MC, Calès P. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2009;21:28-38. [PMID: 19060630 DOI: 10.1097/MEG.0b013e32830cebd7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 118 |
Castéra L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, de Lédinghen V. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009;50:59-68. [PMID: 19013661 DOI: 10.1016/j.jhep.2008.08.018] [Cited by in Crossref: 272] [Cited by in F6Publishing: 287] [Article Influence: 19.4] [Reference Citation Analysis]
|
| 119 |
Calès P, Boursier J, Oberti F, Gallois Y, Rousselet MC, Moal V, Macchi L, Chevailler A, Lunel F. [FibroMeters: a family of blood tests for liver fibrosis with high diagnostic performance and applicability in clinical practice]. Pathol Biol (Paris) 2009;57:459-62. [PMID: 19054629 DOI: 10.1016/j.patbio.2008.09.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 120 |
Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, Brevet M, Grignon P, Lion S, Le Page L, Dupas JL. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 2008;28:1188-98. [PMID: 18705692 DOI: 10.1111/j.1365-2036.2008.03831.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 140] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 121 |
Zois CD, Baltayiannis GH, Karayiannis P, Tsianos EV. Systematic review: hepatic fibrosis - regression with therapy. Aliment Pharmacol Ther 2008;28:1175-87. [PMID: 18761707 DOI: 10.1111/j.1365-2036.2008.03840.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 122 |
Kuwahara R, Kumashiro R, Ide T, Koga Y, Hino T, Hisamochi A, Tanaka K, Ogata K, Koga H, Takao Y, Sata M. Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV. Dig Dis Sci 2008;53:2999-3006. [PMID: 18618250 DOI: 10.1007/s10620-008-0384-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 123 |
Calès P, de Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, Foucher J, Bourlière M, de Muret A, Sturm N, Hunault G, Oberti F. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int 2008;28:1352-62. [PMID: 18492022 DOI: 10.1111/j.1478-3231.2008.01789.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 124 |
Shiha G. Serum hyaluronic acid: a promising marker of hepatic fibrosis in chronic hepatitis B. Saudi J Gastroenterol 2008;14:161-2. [PMID: 19568531 DOI: 10.4103/1319-3767.43272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 125 |
Paggi S, Colli A, Fraquelli M, Viganò M, Del Poggio P, Facciotto C, Colombo M, Ronchi G, Conte D. A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validation. J Hepatol 2008;49:564-71. [PMID: 18706734 DOI: 10.1016/j.jhep.2008.07.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 126 |
Fontanges T, Bailly F, Trepo E, Chevallier M, Maynard-muet M, Nalet B, Beorchia S, Pillon D, Moindrot H, Froissart B, Slaoui M, Tinel X, Pradat P, Trepo C. Discordance between biochemical markers of liver activity and fibrosis (Actitest®–Fibrotest®) and liver biopsy in patients with chronic hepatitis C. Gastroentérologie Clinique et Biologique 2008;32:858-65. [DOI: 10.1016/j.gcb.2008.05.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 127 |
D’onofrio M, Ruzzenente A, Martone E, Manfrin E, Malagò R, Casarin A, Mucelli RP. Procedure diagnostiche. Ecografia e procedure interventistiche percutanee. [DOI: 10.1007/978-88-470-1062-8_1] [Reference Citation Analysis]
|
| 128 |
Calès P, Dib N, Oberti F. Prevention of first variceal bleeding. Liver Cirrhosis: From Pathophysiology to Disease Management. [DOI: 10.1007/978-1-4020-8656-4_20] [Reference Citation Analysis]
|
| 129 |
Wong GL, Wong VW, Choi PC, Chan AW, Chum RH, Chan HK, Lau KK, Chim AM, Yiu KK, Chan FK, Sung JJ, Chan HL. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 2008;6:1027-35. [PMID: 18456573 DOI: 10.1016/j.cgh.2008.02.038] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 130 |
Castera L. Assessing liver fibrosis. Expert Rev Gastroenterol Hepatol 2008;2:541-52. [PMID: 19072402 DOI: 10.1586/17474124.2.4.541] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 131 |
Abbattista T, Ridolfi F, Ciabattoni E, Marini F, Bendia E, Brunelli E, Busilacchi P. Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography. Radiol Med. 2008;113:860-874. [PMID: 18587531 DOI: 10.1007/s11547-008-0292-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 132 |
Keedy A, Westphalen AC, Qayyum A, Aslam R, Rybkin AV, Chen MH, Coakley FV. Diagnosis of cirrhosis by spiral computed tomography: a case-control study with feature analysis and assessment of interobserver agreement. J Comput Assist Tomogr 2008;32:198-203. [PMID: 18379301 DOI: 10.1097/RCT.0b013e31815ea857] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 133 |
Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02. J Hepatol 2008;48:765-73. [PMID: 18314219 DOI: 10.1016/j.jhep.2008.01.025] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 134 |
Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology 2008;134:1670-81. [PMID: 18471546 DOI: 10.1053/j.gastro.2008.03.001] [Cited by in Crossref: 303] [Cited by in F6Publishing: 321] [Article Influence: 20.2] [Reference Citation Analysis]
|
| 135 |
Lieber CS, Weiss DG, Paronetto F. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol Clin Exp Res. 2008;32:1031-1039. [PMID: 18422837 DOI: 10.1111/j.1530-0277.2008.00664.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 136 |
Mehta P, Ploutz-Snyder R, Nandi J, Rawlins SR, Sanderson SO, Levine RA. Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C. Am J Gastroenterol 2008;103:928-36. [PMID: 18371145 DOI: 10.1111/j.1572-0241.2007.01761.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 137 |
Thomas DL, Sulkowski MS. Detection of Liver Disease in Injection Drug Users. Journal of Addictive Diseases 2008;27:19-24. [DOI: 10.1300/j069v27n02_03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 138 |
Halfon P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Cacoub P. Effect of Antiviral Treatment on Serum Markers of Liver Fibrosis in HIV–Hepatitis C virus-Coinfected Patients: The Fibrovic 2 Study – ANRS HC02. Antiviral Therapy 2009;14:211-9. [DOI: 10.1177/135965350901400205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 139 |
D'amico G, Garcia-tsao G, Cales P, Escorsell A, Nevens F, Cestari R, Caletti G, Zoli M. Session 2 - Diagnosis of Portal Hypertension: How and When. In: de Franchis R, editor. Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science Ltd; 2001. pp. 36-64. [DOI: 10.1002/9780470760154.ch4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 140 |
Kim MY, Baik SK, Jang YO, Suk KT, Kim JW, Kim HS, Cho MY, Choi SJ, Um SH, Han K. Serum hyaluronic acid level: Correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model. Korean J Hepatol 2008;14:159. [DOI: 10.3350/kjhep.2008.14.2.159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 141 |
Lorenzo-Zúñiga V, Bartolí R, Masnou H, Montoliu S, Morillas RM, Planas R. Serum concentrations of insulin-like growth factor-I (igf-I) as a marker of liver fibrosis in patients with chronic hepatitis C. Dig Dis Sci 2007;52:3245-50. [PMID: 17410466 DOI: 10.1007/s10620-006-9437-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 142 |
Ridolfi F, Abbattista T, Marini F, Vedovelli A, Quagliarini P, Busilacchi P, Brunelli E. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig Liver Dis 2007;39:929-35. [PMID: 17669702 DOI: 10.1016/j.dld.2007.06.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 143 |
Aubé C, Moal F, Oberti F, Roux J, Croquet V, Gallois Y, Argaud C, Caron C, Calès P. Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats. Dig Dis Sci 2007;52:2601-9. [PMID: 17429735 DOI: 10.1007/s10620-006-9143-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 144 |
Cho JH, Park KH, Kim SH, Bang JH, Park WB, Kim HB, Kim NJ, Oh MD, Lee HS, Choe KW. Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis. Scand J Infect Dis. 2007;39:697-702. [PMID: 17654346 DOI: 10.1080/00365540701299582] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 145 |
Calès P, Veillon P, Konaté A, Mathieu E, Ternisien C, Chevailler A, Godon A, Gallois Y, Joubaud F, Hubert-Fouchard I. Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem. 2008;41:10-18. [PMID: 17988658 DOI: 10.1016/j.clinbiochem.2007.08.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 146 |
Isman FK, Kucur M, Baysal B, Ozkan F. Evaluation of serum hyaluronic acid level and hyaluronidase activity in acute and chronic hepatitis C. J Int Med Res 2007;35:346-52. [PMID: 17593863 DOI: 10.1177/147323000703500309] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 147 |
Aoyama K, Tsuchiya M, Mori K, Kubo Y, Shiraishi K, Sakaguchi E, Yamashita S, Sakaida I. Effect of a late evening snack on outpatients with liver cirrhosis. Hepatol Res 2007;37:608-14. [PMID: 17517075 DOI: 10.1111/j.1872-034X.2007.00036.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 148 |
Guimond A, Teletin M, Garo E, D'Sa A, Selloum M, Champy MF, Vonesch JL, Monassier L. Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodelling in mice. Liver Int 2007;27:854-64. [PMID: 17617129 DOI: 10.1111/j.1478-3231.2007.01493.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 149 |
Guéchot J, Vaubourdolle M. Évaluation Non Invasive de la Fibrose Hépatique au Cours des Hépatites Chroniques Virales C. Revue Francophone des Laboratoires 2007;2007:33-40. [DOI: 10.1016/s1773-035x(07)80302-9] [Reference Citation Analysis]
|
| 150 |
Desmyter L, Fan YD, Praet M, Jaworski T, Vervecken W, De Hemptinne B, Contreras R, Chen C. Rating of CCl(4)-induced rat liver fibrosis by blood serum glycomics. J Gastroenterol Hepatol 2007;22:1148-54. [PMID: 17608861 DOI: 10.1111/j.1440-1746.2006.04553.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 151 |
Males S, Gad RR, Esmat G, Abobakr H, Anwar M, Rekacewicz C, Hoseiny ME, Zalata K, Abdel-hamid M, Bedossa P, Pol S, Mohamed MK, Fontanet A. Serum α-Foetoprotein Level Predicts Treatment Outcome in Chronic Hepatitis C. Antiviral Therapy 2007;12:797-803. [DOI: 10.1177/135965350701200506] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 152 |
Hardy S, Kleinman RE. Cirrhosis and Chronic Liver Failure. Liver Disease in Children 2007. [DOI: 10.1017/cbo9780511547409.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 153 |
Lunel-Fabiani F. Recent advances in hepatitis C virus research and understanding the biology of the virus. World J Gastroenterol 2007; 13(17): 2404-2405 [PMID: 17552022 DOI: 10.3748/wjg.v13.i17.2404] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 154 |
Burroughs AK, Cholongitas E. Non-invasive tests for liver fibrosis: encouraging or discouraging results? J Hepatol 2007;46:751-5. [PMID: 17383047 DOI: 10.1016/j.jhep.2007.02.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 155 |
Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360-9. [PMID: 17439526 DOI: 10.1111/j.1365-2893.2006.00811.x] [Cited by in Crossref: 484] [Cited by in F6Publishing: 441] [Article Influence: 30.3] [Reference Citation Analysis]
|
| 156 |
Esmat G, Metwally M, Zalata KR, Gadalla S, Abdel-Hamid M, Abouzied A, Shaheen AA, El-Raziky M, Khatab H, El-Kafrawy S, Mikhail N, Magder LS, Afdhal NH, Strickland GT. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. J Hepatol 2007;46:620-7. [PMID: 17316875 DOI: 10.1016/j.jhep.2006.12.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 157 |
Dib N, Sawadogo A, Boursier J, Calès P. Évaluation non invasive de la fibrose hépatique au cours des co-infections VIH et VHC et/ou VHB. J Afr Hepato Gastroenterol 2007;1:54-58. [DOI: 10.1007/s12157-007-0012-y] [Reference Citation Analysis]
|
| 158 |
Sumida Y, Kanemasa K, Fukumoto K, Yoshida N, Sakai K. Correlation of hepatic steatosis with body mass index, serum ferritin level and hepatic fibrosis in Japanese patients with chronic hepatitis C. Hepatol Res 2007;37:263-9. [PMID: 17397514 DOI: 10.1111/j.1872-034X.2007.00038.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 159 |
Halfon P, Bourlière M, Pénaranda G, Cacoub P. Intérêt et limites des méthodes non invasives de prédiction de la fibrose hépatique au cours de l'hépatite C: une alternative à la biopsie hépatique. La Presse Médicale 2007;36:457-66. [DOI: 10.1016/j.lpm.2007.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 160 |
Yilmaz Ş, Bayan K, Tüzün Y, Dursun M, Kaplan A, Özmen Ş, Canoruç F, Akkuş Z. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis: Value of hyaluronic acid and hscrp in chronic viral hepatitis. International Journal of Clinical Practice 2007;61:438-43. [DOI: 10.1111/j.1742-1241.2006.00912.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 161 |
Nguyen-khac E. Résultats et place du Fibroscan® dans le diagnostic non invasif de la fibrose hépatique. La Revue de Médecine Interne 2007;28:94-102. [DOI: 10.1016/j.revmed.2006.10.329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 162 |
Voitot H. Biologie et cirrhose. Revue Francophone des Laboratoires 2006;2006:65-71. [DOI: 10.1016/s1773-035x(06)80500-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 163 |
Calmus Y, Conti F, Vaubourdolle M. Le suivi biologique avant et après transplantation hépatique. Revue Francophone des Laboratoires 2006;2006:79-86. [DOI: 10.1016/s1773-035x(06)80502-2] [Reference Citation Analysis]
|
| 164 |
Nguyen-Khac E, Capron D. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan). Eur J Gastroenterol Hepatol 2006;18:1321-5. [PMID: 17099382 DOI: 10.1097/01.meg.0000243884.55562.37] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 165 |
Luxon BA. Noninvasive tests for liver fibrosis. Postgrad Med 2006;119:8-13. [PMID: 17128639 DOI: 10.1080/00325481.2006.11446044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 166 |
Li ZX, He Y, Wu J, Liang DM, Zhang BL, Yang H, Wang LL, Ma Y, Wei KL. Noninvasive evaluation of hepatic fibrosis in children with infant hepatitis syndrome. World J Gastroenterol 2006; 12(44): 7155-7160 [PMID: 17131478 DOI: 10.3748/wjg.v12.i44.7155] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 167 |
Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection. Liver Int 2006;26:1095-9. [PMID: 17032410 DOI: 10.1111/j.1478-3231.2006.01356.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 168 |
Guéchot J. [Noninvasive assessment of liver fibrosis in patients with chronic hepatitis virus C]. Presse Med. 2006;35:1317-1326. [PMID: 16969327 DOI: 10.1016/s0755-4982(06)74811-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 169 |
London WT, Mcglynn KA. Liver Cancer. Cancer Epidemiology and Prevention 2006. [DOI: 10.1093/acprof:oso/9780195149616.003.0039] [Cited by in Crossref: 57] [Cited by in F6Publishing: 169] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 170 |
Sulkowski MS, Thomas DL. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment. Clin Infect Dis 2005;40 Suppl 5:S263-9. [PMID: 15768333 DOI: 10.1086/427440] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 171 |
Serpaggi J, Carnot F, Nalpas B, Canioni D, Guéchot J, Lebray P, Vallet-Pichard A, Fontaine H, Bedossa P, Pol S. Direct and indirect evidence for the reversibility of cirrhosis. Hum Pathol 2006;37:1519-26. [PMID: 16997354 DOI: 10.1016/j.humpath.2006.07.007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 172 |
Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S, Diamantis I. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease. Liver Int 2006;26:864-71. [PMID: 16911470 DOI: 10.1111/j.1478-3231.2006.01312.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 173 |
Kaneda H, Hashimoto E, Yatsuji S, Tokushige K, Shiratori K. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2006;21:1459-65. [PMID: 16911693 DOI: 10.1111/j.1440-1746.2006.04447.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 34] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 174 |
Gómez-Domínguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, García-Buey L, Moreno-Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 2006;24:513-8. [PMID: 16886917 DOI: 10.1111/j.1365-2036.2006.02999.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 175 |
Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12(23): 3682-3694 [PMID: 16773685 DOI: 10.3748/wjg.v12.i23.3682] [Cited by in CrossRef: 183] [Cited by in F6Publishing: 195] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 176 |
Halfon P, Bourlière M, Pénaranda G, Cacoub P. [Serum markers of non-invasive fibrosis in chronic hepatitis C virus infection]. Rev Med Interne 2006;27:751-61. [PMID: 16815598 DOI: 10.1016/j.revmed.2006.03.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 177 |
Zesong L, Shaoxi C, Yuan J, Ruijun G, Wen Z. Colchicine inhibited the expression of tissue inhibitor of metalloprotenase-1 and interleukin-6 in cultured activated hepatic stellate cells. Wuhan Univ J Nat Sci 2006;11:720-724. [DOI: 10.1007/bf02836697] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 178 |
Testa E, Malfatti F, Milazzo S, Cordiviola C, Cotellessa T, Marabotto E, Giannini E, Ceppa P, Mamone M, Risso D, Testa R. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease. Liver Int 2006;26:439-44. [PMID: 16629647 DOI: 10.1111/j.1478-3231.2006.01251.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 179 |
Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver Fibrosis: Noninvasive Diagnosis with Double Contrast Material–enhanced MR Imaging. Radiology 2006;239:425-37. [DOI: 10.1148/radiol.2392050505] [Cited by in Crossref: 148] [Cited by in F6Publishing: 157] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 180 |
Oberti F. Cas clinique. Gastroentérologie Clinique et Biologique 2006;30:554-557. [DOI: 10.1016/s0399-8320(06)73225-0] [Reference Citation Analysis]
|
| 181 |
Lebensztejn DM, Skiba E, Tobolczyk J, Sobaniec-Lotowska ME, Kaczmarski M. Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis. World J Gastroenterol 2005;11:7192-6. [PMID: 16437671 DOI: 10.3748/wjg.v11.i45.7192] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 182 |
Colli A, Colucci A, Paggi S, Fraquelli M, Massironi S, Andreoletti M, Michela V, Conte D. Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C. World J Gastroenterol 2005;11:7318-22. [PMID: 16437635 DOI: 10.3748/wjg.v11.i46.7318] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 183 |
Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-Allieri A, Rotily M, Sattonet C, Benderitter T, Saint Paul MC, Bonnot HP, Penaranda G, Degott C, Masseyeff MF, Ouzan D. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol 2006;101:547-55. [PMID: 16542291 DOI: 10.1111/j.1572-0241.2006.00411.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 184 |
Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Pirisi M. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index. Clin Biochem 2006;39:339-43. [PMID: 16487951 DOI: 10.1016/j.clinbiochem.2006.01.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 185 |
Schöniger-Hekele M, Müller C. The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis. Dig Dis Sci 2006;51:338-45. [PMID: 16534678 DOI: 10.1007/s10620-006-3135-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 186 |
Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, Stuver S, Horsburgh CR Jr. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr. 2005;40:538-544. [PMID: 16284529 DOI: 10.1097/01.qai.0000184856.31695.bf] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 187 |
Dufour DR. Assessment of liver fibrosis: Can serum become the sample of choice. Clin Chem. 2005;51:1763-1764. [PMID: 16189374 DOI: 10.1373/clinchem.2005.056929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 188 |
Obrador BD, Prades MG, Gómez MV, Domingo JP, Cueto RB, Rué M, Real J, Guiteras PM. A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical, laboratory, and ultrasound findings. Eur J Gastroenterol Hepatol 2006;18:57-62. [PMID: 16357620 DOI: 10.1097/00042737-200601000-00010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 189 |
Blanc J, de Ledinghen V, Rosenbaum J. Fibrose hépatique. EMC - Hépatologie 2006;1:1-7. [DOI: 10.1016/s1155-1976(06)31588-4] [Reference Citation Analysis]
|
| 190 |
Gandon Y, Olivié D, Juhel C, Rohou T, Aubé C. Hépatopathies de surcharge et cirrhose. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2006;1:1-17. [DOI: 10.1016/s1879-8527(06)74718-9] [Reference Citation Analysis]
|
| 191 |
Huang H, Zhou J, Huang Y, Bao M. Development of a multi-channel immunosensor for determnination of serum hepatic fibrosis markers. 2006 1st IEEE International Conference on Nano/Micro Engineered and Molecular Systems 2006. [DOI: 10.1109/nems.2006.334575] [Reference Citation Analysis]
|
| 192 |
Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, Chen CW, Wang JY, Cai X, Gao CF, Zhou XQ. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology 2005;42:1437-45. [PMID: 16317674 DOI: 10.1002/hep.20960] [Cited by in Crossref: 118] [Cited by in F6Publishing: 128] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 193 |
Friedenberg MA, Miller L, Chung CY, Fleszler F, Banson FL, Thomas R, Swartz KP, Friedenberg FK. Simplified method of hepatic fibrosis quantification: design of a new morphometric analysis application. Liver Int 2005;25:1156-61. [PMID: 16343066 DOI: 10.1111/j.1478-3231.2005.01161.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 194 |
Schneider AR, Teuber G, Kriener S, Caspary WF. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection. Liver Int 2005;25:1150-5. [PMID: 16343065 DOI: 10.1111/j.1478-3231.2005.01164.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 195 |
Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, Gallois Y, Ternisien C, Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005;42:1373-81. [PMID: 16317693 DOI: 10.1002/hep.20935] [Cited by in Crossref: 392] [Cited by in F6Publishing: 413] [Article Influence: 21.8] [Reference Citation Analysis]
|
| 196 |
Kelleher TB, Afdhal N. Noninvasive assessment of liver fibrosis. Clin Liver Dis 2005;9:667-83, vii. [PMID: 16207570 DOI: 10.1016/j.cld.2005.08.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 197 |
Fraser JR, Gibson PR. Mechanisms by which food intake elevates circulating levels of hyaluronan in humans. J Intern Med 2005;258:460-6. [PMID: 16238682 DOI: 10.1111/j.1365-2796.2005.01564.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 198 |
Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani A, Derakhshan MH, Zamani F, Samiee S, Malekzadeh R. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol 2005;5:32. [PMID: 16221307 DOI: 10.1186/1471-230X-5-32] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 199 |
Su WP, Wen CC, Hsiung CA, Su IJ, Cheng AL, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu C, Hsu CH, Lu YS, Tien HF, Chao TY, Chen LT, Whang-Peng J, Chen PJ. Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients. World J Gastroenterol 2005; 11(34): 5283-5288 [PMID: 16149133 DOI: 10.3748/wjg.v11.i34.5283] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 200 |
Park GJ, Katelaris PH, Jones DB, Seow F, Lin BP, Le Couteur DG, Ngu MC. The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Aliment Pharmacol Ther 2005;22:395-403. [PMID: 16128677 DOI: 10.1111/j.1365-2036.2005.02623.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 201 |
Tan KT, Rajan DK, Kachura JR, Hayeems E, Simons ME, Ho CS. Pain after Percutaneous Liver Biopsy for Diffuse Hepatic Disease: A Randomized Trial Comparing Subcostal and Intercostal Approaches. Journal of Vascular and Interventional Radiology 2005;16:1215-9. [DOI: 10.1097/01.rvi.0000173282.14018.79] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 202 |
Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int 2005;25:779-86. [PMID: 15998429 DOI: 10.1111/j.1478-3231.2005.01064.x] [Cited by in Crossref: 146] [Cited by in F6Publishing: 151] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 203 |
Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005;9:383-98, vi. [PMID: 16023972 DOI: 10.1016/j.cld.2005.05.003] [Cited by in Crossref: 271] [Cited by in F6Publishing: 282] [Article Influence: 15.1] [Reference Citation Analysis]
|
| 204 |
Lebensztejn DM, Sobaniec-Łotowska ME, Bauer M, Kaczmarski M, Voelker M, Schuppan D. Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B. Eur J Gastroenterol Hepatol 2005;17:843-8. [PMID: 16003134 DOI: 10.1097/00042737-200508000-00011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 205 |
Halfon P, Bourlière M, Pénaranda G, Deydier R, Renou C, Botta-Fridlund D, Tran A, Portal I, Allemand I, Rosenthal-Allieri A. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol. 2005;4:6. [PMID: 16008833 DOI: 10.1186/1476-5926-4-6] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 206 |
Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005;42 Suppl:S22-36. [PMID: 15777570 DOI: 10.1016/j.jhep.2004.12.008] [Cited by in Crossref: 176] [Cited by in F6Publishing: 190] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 207 |
Lee HS, Shun CT, Chiou LL, Chen CH, Huang GT, Sheu JC. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability. J Gastroenterol Hepatol 2005;20:1109-14. [PMID: 15955222 DOI: 10.1111/j.1440-1746.2005.03901.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 208 |
Marrache F, Consigny Y, Ripault MP, Cazals-Hatem D, Martinot M, Boyer N, Degott C, Valla D, Marcellin P. Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis. J Viral Hepat 2005;12:421-8. [PMID: 15985014 DOI: 10.1111/j.1365-2893.2005.00609.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 209 |
Gordon A, Bailey MJ, Gibson PR, Roberts SK. Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C. J Gastroenterol Hepatol 2005;20:825-32. [PMID: 15946128 DOI: 10.1111/j.1440-1746.2005.03828.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 210 |
Kronenberger B, Wagner M, Herrmann E, Mihm U, Piiper A, Sarrazin C, Zeuzem S. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. J Viral Hepat 2005;12:307-14. [PMID: 15850472 DOI: 10.1111/j.1365-2893.2005.00594.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 211 |
Eboumbou C, Steghens JP, Abdallahi OM, Mirghani A, Gallian P, van Kappel A, Qurashi A, Gharib B, De Reggi M. Circulating markers of oxidative stress and liver fibrosis in Sudanese subjects at risk of schistosomiasis and hepatitis. Acta Trop 2005;94:99-106. [PMID: 15814296 DOI: 10.1016/j.actatropica.2005.03.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 212 |
Park G, Katelaris P, Jones DB, Ngu M, Le Couteur D. Caution before embracing serum markers of liver fibrosis in clinical practice. Gastroenterology 2005;128:1145-6; author reply 1146. [PMID: 15825107 DOI: 10.1053/j.gastro.2005.02.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 213 |
Iacobellis A, Mangia A, Leandro G, Clemente R, Festa V, Attino V, Ricciardi R, Giacobbe A, Facciorusso D, Andriulli A. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis. Am J Gastroenterol 2005;100:868-73. [PMID: 15784034 DOI: 10.1111/j.1572-0241.2005.40881.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 214 |
Benlloch S, Berenguer M, Prieto M, Rayón JM, Aguilera V, Berenguer J. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index. Liver Transpl 2005;11:456-62. [PMID: 15776403 DOI: 10.1002/lt.20381] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 215 |
Hirota M, Kaneko T, Sugimoto H, Kure S, Inoue S, Takeda S, Nakao A. Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis. Liver Int 2005;25:337-42. [PMID: 15780059 DOI: 10.1111/j.1478-3231.2005.01085.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 216 |
Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Lédinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50. [PMID: 15685546 DOI: 10.1053/j.gastro.2004.11.018] [Cited by in Crossref: 1796] [Cited by in F6Publishing: 1878] [Article Influence: 99.8] [Reference Citation Analysis]
|
| 217 |
Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, Poynard T. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 2005;3:167-74. [PMID: 15704051 DOI: 10.1016/s1542-3565(04)00625-1] [Cited by in Crossref: 105] [Cited by in F6Publishing: 113] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 218 |
Reichen J. Evaluation of Portal Hemodynamics Using Indicator Dilution and Noninvasive Techniques. Portal Hypertension 2005. [DOI: 10.1007/978-1-59259-885-4_10] [Reference Citation Analysis]
|
| 219 |
Aubé C, Racineux PX, Lebigot J, Oberti F, Croquet V, Argaud C, Calès P, Caron C. [Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results]. J Radiol. 2004;85:301-306. [PMID: 15192522 DOI: 10.1016/s0221-0363(04)97582-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 59] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 220 |
Xiao-xia G, Qin Y, Ru-jia X, Xin-hua L, Cheng-xiu L, Ming-liang C. Effect of Danshao Huaxian capsule on the expression of collagen I, III, and caspase-3 in hepatic fibrosis rats. Chin J Integr Med 2004;10:289-95. [DOI: 10.1007/bf02836432] [Reference Citation Analysis]
|
| 221 |
Gandon Y, Olivié D, Juhel C, Rohou T, Aubé C. Hépatopathies de surcharge et cirrhose. EMC - Radiologie 2004;1:665-687. [DOI: 10.1016/j.emcrad.2004.08.003] [Reference Citation Analysis]
|
| 222 |
Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004;41:935-42. [PMID: 15582126 DOI: 10.1016/j.jhep.2004.08.008] [Cited by in Crossref: 242] [Cited by in F6Publishing: 251] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 223 |
Abergel A, Darcha C, Chevallier M, Ughetto S, Henquell C, Pol S, de Ledinghen V, Canva V, Bronowicki JP, Tran A, Martineau N, Lafeuille H, Dechelotte P, Bommelaer G, Bonny C; French Multicentre Study Group. Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis. Eur J Gastroenterol Hepatol 2004;16:1219-27. [PMID: 15489585 DOI: 10.1097/00042737-200411000-00022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 224 |
Chongsrisawat V, Kongtawelert P, Tongsoongnoen W, Tangkijvanich P, Vejchapipat P, Poovorawan Y. Serum hyaluronan as a marker reflecting the severity of cirrhosis and portal hypertension in postoperative biliary atresia. Pediatr Surg Int 2004;20:773-7. [PMID: 15168048 DOI: 10.1007/s00383-004-1141-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 225 |
Bezerra ASDA, D'ippolito G, Caldana RP, Cecin AO, Szejnfeld J. Avaliação hepática e esplênica por ressonância magnética em pacientes portadores de esquistossomose mansônica crônica. Radiol Bras 2004;37:313-21. [DOI: 10.1590/s0100-39842004000500003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 226 |
Quereda C, Moreno S, Moreno L, Moreno A, Garcı́a-sanmiguel L, Pérez-elı́as MJ, Navas E, Dronda F, Moreno A, Casado J, Antela A, López-san Román A. The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus. Human Pathology 2004;35:1083-7. [DOI: 10.1016/j.humpath.2004.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 227 |
Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ. Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004; 10(15): 2284-2286 [PMID: 15259084 DOI: 10.3748/wjg.v10.i15.2284] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 228 |
Aubé C, Winkfield B, Oberti F, Vuillemin E, Rousselet MC, Caron C, Calès P. New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol 2004;16:743-51. [PMID: 15256975 DOI: 10.1097/01.meg.0000108357.41221.e5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 229 |
Calès P. Mesure de la fibrose hépatique. EMC - Hépatologie 2004;1:99-106. [DOI: 10.1016/j.emchep.2004.04.001] [Reference Citation Analysis]
|
| 230 |
Gómez JA, Molero X, Vaquero E, Alonso A, Salas A, Malagelada JR. Vitamin E attenuates biochemical and morphological features associated with development of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2004;287:G162-9. [PMID: 15001429 DOI: 10.1152/ajpgi.00333.2003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 231 |
Trinchet JC, Grando-Lemaire V. [Diagnosis of cirrhosis]. Gastroenterol Clin Biol 2004;28:D121-8. [PMID: 15213672 DOI: 10.1016/s0399-8320(04)94996-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 232 |
Lainé F, Bendavid C, Moirand R, Tessier S, Perrin M, Guillygomarc'h A, Guyader D, Calon E, Renault A, Brissot P, Turlin B, Deugnier Y. Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption. Hepatology 2004;39:1639-46. [PMID: 15185305 DOI: 10.1002/hep.20219] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 233 |
Lucidarme D, Filoche B. Traitement de l’hépatite C et toxicomanie : le stade de fibrose « cliniquement significative » est-il le bon argument décisionnel ? Gastroentérologie Clinique et Biologique 2004;28:529-531. [DOI: 10.1016/s0399-8320(04)95007-5] [Reference Citation Analysis]
|
| 234 |
Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-74. [PMID: 15180741 DOI: 10.1111/j.1572-0241.2004.30110.x] [Cited by in Crossref: 424] [Cited by in F6Publishing: 437] [Article Influence: 22.3] [Reference Citation Analysis]
|
| 235 |
Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN, Morel F, Zarski JP. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 2004;99:271-9. [PMID: 15046217 DOI: 10.1111/j.1572-0241.2004.04055.x] [Cited by in Crossref: 184] [Cited by in F6Publishing: 182] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 236 |
Ohtaki M, Yagi M, Kubota M, Homma S. A disturbance of the gastric myoelectric activity in post-operative patients with biliary atresia. Pediatr Surg Int 2004;20:77-82. [PMID: 14722717 DOI: 10.1007/s00383-003-1091-5] [Reference Citation Analysis]
|
| 237 |
Adrover R, Cocozzella D, Borzi S, Montenegro L, Defelitto M, Bosia D, Fraquelli E, Curciarello J. ¿Cuándo sería más rentable realizar una endoscopia digestiva alta para establecer la presencia de varices esofágicas en pacientes con cirrosis? Gastroenterología y Hepatología 2004;27:353-6. [DOI: 10.1016/s0210-5705(03)70474-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 238 |
Dahab GM, Kheriza MM, El-Beltagi HM, Fouda AM, El-Din OA. Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol 2004;19:78-85. [PMID: 14675247 DOI: 10.1111/j.1440-1746.2004.03183.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 239 |
Lu LG, Zeng MD, Mao YM, Li JQ, Qiu DK, Fang JY, Cao AP, Wan MB, Li CZ, Ye J, Cai X, Chen CW, Wang JY, Wu SM, Zhu JS, Zhou XQ. Relationship between clinical and pathologic findings in patients with chronic liver diseases. World J Gastroenterol 2003; 9(12): 2796-2800 [PMID: 14669336 DOI: 10.3748/wjg.v9.i12.2796] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 240 |
Guéchot J. Évaluation de la fibrose hépatique. Revue Française des Laboratoires 2003;2003:39-43. [DOI: 10.1016/s0338-9898(03)90045-x] [Reference Citation Analysis]
|
| 241 |
Forns X, Bataller R. Can we identify liver fibrosis in HCV-infected patients without a liver biopsy? Curr hepatitis rep 2003;2:145-51. [DOI: 10.1007/s11901-003-0016-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 242 |
Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-57. [PMID: 14647056 DOI: 10.1016/j.hep.2003.09.022] [Cited by in Crossref: 1193] [Cited by in F6Publishing: 1385] [Article Influence: 59.7] [Reference Citation Analysis]
|
| 243 |
Körner T, Kropf J, Kosche B, Kristahl H, Jaspersen D, Gressner AM. Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. J Hepatol 2003;39:947-53. [PMID: 14642610 DOI: 10.1016/s0168-8278(03)00431-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 244 |
Zhang BB, Cai WM, Weng HL, Hu ZR, Lu J, Zheng M, Liu RH. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-β1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis. World J Gastroenterol 2003; 9(11): 2490-2496 [PMID: 14606082 DOI: 10.3748/wjg.v9.i11.2490] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 53] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 245 |
Lu LG, Zeng MD, Wan MB, Li CZ, Mao YM, Li JQ, Qiu DK, Cao AP, Ye J, Cai X, Chen CW, Wang JY, Wu SM, Zhu JS, Zhou XQ. Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World J Gastroenterol 2003; 9(11): 2574-2578 [PMID: 14606100 DOI: 10.3748/wjg.v9.i11.2574] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 49] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 246 |
Tao J, Peng HQ, Cai WM, Dong FQ, Weng HL, Liu RH. Influence factors of serum fibrosis markers in liver fibrosis. World J Gastroenterol 2003; 9(11): 2497-2500 [PMID: 14606083 DOI: 10.3748/wjg.v9.i11.2497] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 247 |
Reuben A. Just a second. Hepatology 2003;38:1316-20. [PMID: 14578876 DOI: 10.1002/hep.510380537] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 248 |
Phillips MG, Preedy VR, Hughes RD. Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy? Eur J Gastroenterol Hepatol 2003;15:941-4. [PMID: 12923364 DOI: 10.1097/00042737-200309000-00001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 249 |
Stickel F, Poeschl G, Schuppan D, Conradt C, Strenge-Hesse A, Fuchs FS, Hofmann WJ, Seitz HK. Serum hyaluronate correlates with histological progression in alcoholic liver disease. Eur J Gastroenterol Hepatol 2003;15:945-50. [PMID: 12923365 DOI: 10.1097/00042737-200309000-00002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 250 |
Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U; EMALD Group. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol 2003;39:179-86. [PMID: 12873813 DOI: 10.1016/s0168-8278(03)00184-3] [Cited by in Crossref: 109] [Cited by in F6Publishing: 117] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 251 |
Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003;38:481-92. [PMID: 12883493 DOI: 10.1053/jhep.2003.50319] [Cited by in Crossref: 188] [Cited by in F6Publishing: 197] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 252 |
Shiramizu B, Theodore D, Bassett R, Coel M, Sherman KE, Glesby MJ, Chow D, Alston B, Colquhoun D, Merigan TC Jr, Reichman RC, Berggren R, Burning WJ, Brobst S; Adult AIDS Clinical Trials Group 5096 Team. Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. J Acquir Immune Defic Syndr 2003;33:329-35. [PMID: 12843743 DOI: 10.1097/00126334-200307010-00006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 253 |
Fehr T, Riehle HM, Nigg L, Grüter E, Ammann P, Renner EL, Ambühl PM. Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters. Am J Kidney Dis 2003;42:193-201. [PMID: 12830472 DOI: 10.1016/s0272-6386(03)00423-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 254 |
N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(6): 789-791 [DOI: 10.11569/wcjd.v11.i6.789] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 255 |
Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 2003;37:972-4. [PMID: 12717376 DOI: 10.1053/jhep.2003.50223] [Cited by in Crossref: 92] [Cited by in F6Publishing: 98] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 256 |
Wietzke-Braun P, Braun F, Schott P, Ramadori G. Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection? World J Gastroenterol 2003; 9(4): 745-750 [PMID: 12679924 DOI: 10.3748/wjg.v9.i4.745] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 257 |
Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases. Radiology 2003;227:89-94. [PMID: 12601199 DOI: 10.1148/radiol.2272020193] [Cited by in Crossref: 231] [Cited by in F6Publishing: 243] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 258 |
Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, Pockros PJ, Blatt LM, Conrad A, McHutchison JG. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol 2003;18:253-7. [PMID: 12603524 DOI: 10.1046/j.1440-1746.2003.02930.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 259 |
Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P; PANFIBROSIS Group. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003;38:257-65. [PMID: 12586290 DOI: 10.1016/s0168-8278(02)00413-0] [Cited by in Crossref: 317] [Cited by in F6Publishing: 331] [Article Influence: 15.9] [Reference Citation Analysis]
|
| 260 |
Kang WZ, Xie YM, Nie QH, Zhang Y, Hao CQ, Wang JP, Chen WH. Effect of Oxymatrine on experimental liver fibrosis. Shijie Huaren Xiaohua Zazhi 2003; 11(2): 195-198 [DOI: 10.11569/wcjd.v11.i2.195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 261 |
Zheng M, Cai WM, Weng HL, Liu RH. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J Gastroenterol 2002; 8(6): 1073-1076 [PMID: 12439928 DOI: 10.3748/wjg.v8.i6.1073] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 262 |
Rydén I, Påhlsson P, Lindgren S. Diagnostic Accuracy of α1-Acid Glycoprotein Fucosylation for Liver Cirrhosis in Patients Undergoing Hepatic Biopsy. Clinical Chemistry 2002;48:2195-201. [DOI: 10.1093/clinchem/48.12.2195] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 263 |
Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002;36:S57-64. [PMID: 12407577 DOI: 10.1053/jhep.2002.36800] [Cited by in Crossref: 21] [Cited by in F6Publishing: 48] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 264 |
Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002;36:S57-64. [PMID: 12407577 DOI: 10.1053/jhep.2002.36800] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 265 |
Pilette C, Calès P. [Are blood markers of hepatic fibrosis available in clinical practice?]. Rev Med Interne 2002;23:885-8. [PMID: 12481387 DOI: 10.1016/s0248-8663(02)00683-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 266 |
Croquet V, Vuillemin E, Ternisien C, Pilette C, Oberti F, Gallois Y, Trossaert M, Rousselet MC, Chappard D, Calès P. Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol 2002;14:1133-41. [PMID: 12362105 DOI: 10.1097/00042737-200210000-00015] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 267 |
Moal F, Chappard D, Wang J, Vuillemin E, Michalak-Provost S, Rousselet MC, Oberti F, Calès P. Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology 2002;36:840-9. [PMID: 12297831 DOI: 10.1053/jhep.2002.35533] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 268 |
Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, Bruguera M, Sánchez-Tapias JM, Rodés J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-92. [PMID: 12297848 DOI: 10.1053/jhep.2002.36128] [Cited by in Crossref: 672] [Cited by in F6Publishing: 751] [Article Influence: 32.0] [Reference Citation Analysis]
|
| 269 |
Calès P, Oberti F. Diagnostic des hépatopathies et de leur sévérité. ITBM-RBM 2002;23:41-8. [DOI: 10.1016/s1297-9562(02)80044-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 270 |
Kaul V, Friedenberg FK, Braitman LE, Anis U, Zaeri N, Fazili J, Herrine SK, Rothstein KD. Development and validation of a model to diagnose cirrhosis in patients with hepatitis C. Am J Gastroenterol 2002;97:2623-8. [PMID: 12385450 DOI: 10.1111/j.1572-0241.2002.06040.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 271 |
Cadranel JF, Mathurin P. Prothrombin index decrease: a useful and reliable marker of extensive fibrosis? Eur J Gastroenterol Hepatol 2002;14:1057-9. [PMID: 12362094 DOI: 10.1097/00042737-200210000-00004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 272 |
Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002;36:673-8. [PMID: 12198660 DOI: 10.1053/jhep.2002.35343] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 273 |
Bernatik T, Strobel D, Hahn EG, Becker D. Doppler measurements: a surrogate marker of liver fibrosis? Eur J Gastroenterol Hepatol 2002;14:383-7. [PMID: 11943950 DOI: 10.1097/00042737-200204000-00008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 274 |
Maiga MY, Dembele M, Diallo F, Traore HA, Traore AK, Guindo A. Valeur diagnostique de l'endoscople digestive haute au cours de la cirrhose. Acta Endosc 2002;32:211-218. [DOI: 10.1007/bf03016657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 275 |
Poynard T, Ratziu V, Moussalli J, Regimbeau C, Martino VD, Benhamou Y, Myers R, Imbert-bismut F. Biopsie du foie contre prise de sang pour le suivi de l’hépatite C ? Med Sci (Paris) 2002;18:353-356. [DOI: 10.1051/medsci/2002183353] [Reference Citation Analysis]
|
| 276 |
El-Sokkary GH, Omar HM, Hassanein AF, Cuzzocrea S, Reiter RJ. Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni. Free Radic Biol Med 2002;32:319-32. [PMID: 11841922 DOI: 10.1016/s0891-5849(01)00753-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 277 |
Calès P, Oberti F, Pilette C, Lauret P. Diagnóstico de la cirrosis del hígado. EMC - Tratado de Medicina 2002;6:1-4. [DOI: 10.1016/s1636-5410(02)70173-6] [Reference Citation Analysis]
|
| 278 |
Veldt BJ, Lainé F, Guillygomarc'h A, Lauvin L, Boudjema K, Messner M, Brissot P, Deugnier Y, Moirand R. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 2002;36:93-8. [PMID: 11804670 DOI: 10.1016/s0168-8278(01)00228-8] [Cited by in Crossref: 139] [Cited by in F6Publishing: 144] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 279 |
de Bruyn G, Graviss EA. A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis. BMC Med Inform Decis Mak 2001;1:6. [PMID: 11806763 DOI: 10.1186/1472-6947-1-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 280 |
Schellenberg F, Nalpas B. [Peripheral markers, future perspectives]. Pathol Biol (Paris) 2001;49:775-80. [PMID: 11762142 DOI: 10.1016/s0369-8114(01)00240-1] [Reference Citation Analysis]
|
| 281 |
Spycher C, Zimmermann A, Reichen J. The diagnostic value of liver biopsy. BMC Gastroenterol 2001;1:12. [PMID: 11707153 DOI: 10.1186/1471-230x-1-12] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 282 |
Murawaki Y, Koda M, Okamoto K, Mimura K, Kawasaki H. Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C. J Gastroenterol Hepatol 2001;16:777-81. [PMID: 11446886 DOI: 10.1046/j.1440-1746.2001.02515.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 283 |
Hirata M, Akbar SM, Horiike N, Onji M. Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus. Eur J Clin Invest 2001;31:528-35. [PMID: 11422403 DOI: 10.1046/j.1365-2362.2001.00840.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 284 |
Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T; MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-75. [PMID: 11297957 DOI: 10.1016/S0140-6736(00)04258-6] [Cited by in Crossref: 1066] [Cited by in F6Publishing: 1113] [Article Influence: 48.5] [Reference Citation Analysis]
|
| 285 |
Oh S, Afdhal NH. Hepatic fibrosis: are any of the serum markers useful? Curr Gastroenterol Rep 2001;3:12-8. [PMID: 11177689 DOI: 10.1007/s11894-001-0035-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 286 |
Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000;46:2050-68. [PMID: 11106350 [PMID: 11106350 DOI: 10.1093/clinchem/46.12.2050] [Cited by in Crossref: 239] [Cited by in F6Publishing: 243] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 287 |
O'Brien MJ, Keating NM, Elderiny S, Cerda S, Keaveny AP, Afdhal NH, Nunes DP. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol 2000;114:712-8. [PMID: 11068544 DOI: 10.1309/D7AU-EYW7-4B6C-K08Y] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 288 |
Hasegawa T, Sasaki, Kimura T, Hoki M, Okada A, Mushiake S, Yagi M, Imura K. Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia. J Pediatr Surg 2000;35:1643-6. [PMID: 11083443 DOI: 10.1053/jpsu.2000.18342] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 289 |
Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000;32:477-81. [PMID: 10960438 DOI: 10.1053/jhep.2000.16602] [Cited by in Crossref: 723] [Cited by in F6Publishing: 767] [Article Influence: 31.4] [Reference Citation Analysis]
|
| 290 |
Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology 2000;32:582-7. [PMID: 10960453 DOI: 10.1053/jhep.2000.9714] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 291 |
Jung SA, Chung YH, Park NH, Lee SS, Kim JA, Yang SH, Song IH, Lee YS, Suh DJ, Moon IH. Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol. Scand J Gastroenterol 2000;35:969-75. [PMID: 11063159 DOI: 10.1080/003655200750023057] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 292 |
McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000;15:945-51. [PMID: 11022838 DOI: 10.1046/j.1440-1746.2000.02233.x] [Cited by in Crossref: 168] [Cited by in F6Publishing: 173] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 293 |
George J. Biochemical markers of hepatic fibrogenesis: single measurements are not reliable enough to replace liver biopsy. J Gastroenterol Hepatol 2000;15:819-21. [PMID: 11022820 DOI: 10.1046/j.1440-1746.2000.02175.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 294 |
Jármay K, Gallai M, Karácsony G, Ozsvár Z, Schaff Z, Lonovics J, Kovalszky I. Decorin and actin expression and distribution in patients with chronic hepatitis C following interferon-alfa-2b treatment. J Hepatol 2000;32:993-1002. [PMID: 10898320 DOI: 10.1016/s0168-8278(00)80104-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 295 |
Guéchot J, Serfaty L, Bonnand AM, Chazouillères O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 2000;32:447-52. [PMID: 10735615 DOI: 10.1016/s0168-8278(00)80396-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 296 |
Li YS, Sleigh AC, Ross AG, Li Y, Williams GM, Tanner M, McManus DP. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements. Trans R Soc Trop Med Hyg 2000;94:191-7. [PMID: 10897367 DOI: 10.1016/s0035-9203(00)90274-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 297 |
Pascal M, Abdallahi OM, Elwali NE, Mergani A, Qurashi MA, Magzoub M, de Reggi M, Gharib B. Hyaluronate levels and markers of oxidative stress in the serum of Sudanese subjects at risk of infection with Schistosoma mansoni. Trans R Soc Trop Med Hyg 2000;94:66-70. [PMID: 10748904 DOI: 10.1016/s0035-9203(00)90443-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 298 |
Pilette C, Oberti F, Aubé C, Rousselet MC, Bedossa P, Gallois Y, Rifflet H, Calès P. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol 1999;31:867-73. [PMID: 10580584 DOI: 10.1016/s0168-8278(99)80288-8] [Cited by in Crossref: 112] [Cited by in F6Publishing: 115] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 299 |
Cadranel JF, Denis J, Pauwels A, Barbare JC, Eugène C, di Martino V, Poquet E, Medini A, Coutarel P, Latrive JP, Lemaître P, Devergie B. Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients. J Hepatol 1999;31:464-8. [PMID: 10488705 DOI: 10.1016/s0168-8278(99)80038-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 300 |
George DK, Ramm GA, Walker NI, Powell LW, Crawford DH. Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol 1999;31:47-52. [PMID: 10424282 DOI: 10.1016/s0168-8278(99)80162-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 301 |
Murawaki Y, Yamada S, Ikuta Y, Kawasaki H. Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease. J Hepatol 1999;30:1090-8. [PMID: 10406188 DOI: 10.1016/s0168-8278(99)80264-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 302 |
Albrecht T, Blomley MJ, Cosgrove DO, Taylor-Robinson SD, Jayaram V, Eckersley R, Urbank A, Butler-Barnes J, Patel N. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999;353:1579-83. [PMID: 10334257 DOI: 10.1016/S0140-6736(98)06373-9] [Cited by in Crossref: 183] [Cited by in F6Publishing: 193] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 303 |
Aubé C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Rifflet H, Maïga MY, Penneau-Fontbonne D, Caron C, Calès P. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999;30:472-8. [PMID: 10190731 DOI: 10.1016/s0168-8278(99)80107-x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 199] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 304 |
Ueno T, Tamaki S, Sugawara H, Sujaku K, Ogata R, Kim K, Torimura T, Sata M, Tanikawa K. Diagnosis and Treatment of Hepatic Fibrosis and Hepatic Sinusoidal Cells. Liver Diseases and Hepatic Sinusoidal Cells 1999. [DOI: 10.1007/978-4-431-67935-6_21] [Reference Citation Analysis]
|
| 305 |
Gong W, Pecci A, Roth S, Lahme B, Beato M, Gressner AM. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology 1998;28:492-502. [PMID: 9696016 DOI: 10.1002/hep.510280229] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 306 |
Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, Maïga MY, Gallois Y, Calès P. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol 1998;28:439-46. [PMID: 9551682 DOI: 10.1016/s0168-8278(98)80318-8] [Cited by in Crossref: 154] [Cited by in F6Publishing: 157] [Article Influence: 6.2] [Reference Citation Analysis]
|
